23.07
0.39%
-0.09
Pre-market:
22.77
-0.30
-1.30%
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $23.07, with a volume of 158.90K.
It is down -0.39% in the last 24 hours and down -2.49% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
See More
Previous Close:
$23.16
Open:
$23.05
24h Volume:
158.90K
Relative Volume:
0.61
Market Cap:
$13.54B
Revenue:
$20.87B
Net Income/Loss:
$715.14M
P/E Ratio:
18.90
EPS:
1.2209
Net Cash Flow:
$1.67B
1W Performance:
+2.58%
1M Performance:
-2.49%
6M Performance:
+16.46%
1Y Performance:
+20.79%
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Compare FMS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
23.07 | 13.54B | 20.87B | 715.14M | 1.67B | 1.2209 |
HCA
Hca Healthcare Inc
|
310.45 | 78.64B | 69.62B | 5.93B | 5.88B | 22.27 |
DVA
Davita Inc
|
166.24 | 14.58B | 12.67B | 827.68M | 1.42B | 9.27 |
THC
Tenet Healthcare Corp
|
130.86 | 12.78B | 20.97B | 3.13B | 2.39B | 31.21 |
UHS
Universal Health Services Inc
|
184.80 | 12.19B | 15.42B | 1.03B | 956.84M | 15.02 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-06-24 | Initiated | Berenberg | Buy |
Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
Aug-14-23 | Downgrade | UBS | Buy → Neutral |
Aug-01-23 | Resumed | Citigroup | Neutral |
Jul-12-23 | Initiated | Goldman | Buy |
Mar-07-23 | Initiated | Bernstein | Mkt Perform |
Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
Nov-23-21 | Initiated | HSBC Securities | Hold |
Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-26-18 | Upgrade | UBS | Neutral → Buy |
Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
Jan-04-18 | Upgrade | UBS | Sell → Neutral |
Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
Aug-02-13 | Reiterated | Feltl & Co. | Hold |
Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Share data - Fresenius Medical Care
Healthcare Professionals overview - Fresenius Medical Care
Company profile - Fresenius Medical Care
China Infusion Systems (Pumps & Pump Disposables) Market Outlook to 2033: Key Companies in China, Pipeline Products, Financial Deals Landscape, Recent Developments & More - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Here's Why Sandoz Group AG Sponsored ADR (SDZNY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Fresenius Medical Care Earnings: Margin Expansion Boosts 2024 Profit Outlook Toward Top End of Goal - Morningstar
Fresenius Medical Care ADR earnings beat by $0.35, revenue fell short of estimates - Investing.com India
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
2024 Healthcare Stocks List | Updated Daily - Sure Dividend
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.
FMS Stock Rides On Diversified Portfolio And Restructuring Initiatives - Barchart
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now - Yahoo Finance
Australia Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Canada Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):